Evidence map›Paper›PMID 33972746›Full record

ReviewBritish journal of cancer2021

COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary.

Thomas Round, Veline L'Esperance, Joanne Bayly, Kate Brain, Lorraine Dallas, John G Edwards, Thomas Haswell, Crispin Hiley, Natasha Lovell, Julia McAdam and 5 more

Abstract readReview
In one paragraph

Review in British journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Transforming post pandemic cancer services.British journal of cancer · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Telemedicine in lung cancer during COVID-19 outbreak: A scoping review.Journal of education and health promotion · 2022
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Thomas RoundSchool of Population Health Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0003-4382-1629
Veline L'EsperanceSchool of Population Health Sciences, King's College London, London, UK.
Joanne BaylyCicely Saunders Institute, King's College London, London, UK.
Kate BrainDivision of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.
Lorraine DallasRoy Castle Lung Cancer Foundation, Liverpool, UK.
John G EdwardsNorthern General Hospital, Sheffield, UK.
Thomas HaswellIndependent Cancer Patient's Voice, London, UK.
Crispin HileyResearch Department of Oncology, Cancer Institute, University College London, London, UK.
Natasha LovellCicely Saunders Institute, King's College London, London, UK.
Julia McAdamShrewsbury and Telford Hospitals NHS Trust, Lung Cancer Nurses UK, Shrewsbury, UK.
Grace McCutchanDivision of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0002-8079-2540
Arjun NairNHS England Targeted Lung Health Checks Programme, Department of Radiology, University College London Hospitals NHS Foundation Trust and Joint Clinical Lead, London, UK.
Thomas Newsom-DavisChelsea and Westminster Hospital, London, UK.
Elizabeth K SageNHS Highland, Inverness, UK.
Neal NavaniLungs For Living Research Centre, University College London and Department of Thoracic Medicine, University College London Hospital, London, UK. n.navani@ucl.ac.uk.ORCID http://orcid.org/0000-0002-6412-7516

Funding

Cancer Research UK 28990Medical Research Council MR/T02481X/1
6 · The paper itself

Abstract

Delivering lung cancer care during the COVID-19 pandemic has posed significant and ongoing challenges. There is a lack of published COVID-19 and lung cancer evidence-based reviews, including for the whole patient pathway. We searched for COVID-19 and lung cancer publications and brought together a multidisciplinary group of stakeholders to review and comment on the evidence and challenges. A rapid review of the literature was undertaken up to 28 October 2020, producing 144 papers, with 113 full texts screened. We focused on new primary data collection (qualitative or quantitative evidence) and excluded case reports, editorials and commentaries. Following exclusions, 15 published papers were included in the review and are summarised. They included one qualitative paper and 14 quantitative studies (surveys or cohort studies), with a total of 2295 lung cancer patients data included (mean study size 153 patients; range 7-803). Review of current evidence and commentary included awareness and help-seeking; lung cancer screening; primary care assessment and referral; diagnosis and treatment in secondary care, including oncology and surgery; patient experience and palliative care. Cross-cutting themes and challenges were identified using qualitative methods for patients, healthcare professionals and service delivery, with a clear need for continued studies to guide evidence-based decision-making.

Indexed as

COVID-19Early Detection of CancerHumansLung NeoplasmsPandemicsSARS-CoV-2

Identifiers

PMID33972746
PMCPMC8108433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.